United States· US:10967-689_2a94aff5-90bf-a99b-e063-6394a90a1efc
Advanced Ceramide Lift and Firm Day Cream
A medicinal product containing homosalate; octocrylene; avobenzone; octisalate, registered in United States by REVLON.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- HOMOSALATE; OCTOCRYLENE; AVOBENZONE; OCTISALATE
- Manufacturer
- REVLON
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 8
- ndc11109676891750 g in 1 JAR (10967-689-17)
- ndc1110967689602 g in 1 PACKET (10967-689-60)
- ndc11109676896115 g in 1 TUBE (10967-689-61)
- ndc1110967689645 g in 1 TUBE (10967-689-64)
- ndc1110967-689-17
- ndc1110967-689-60
- ndc1110967-689-61
- ndc1110967-689-64
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Homosalate; octocrylene; avobenzone; octisalate in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/48d289f7-1454-4a8a-bfe9-b5553f872d5c GET /v1/drugs/48d289f7-1454-4a8a-bfe9-b5553f872d5c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "100; 80; 30; 50",
"substance": "HOMOSALATE; OCTOCRYLENE; AVOBENZONE; OCTISALATE",
"productndc": "10967-689",
"dosage_form": "EMULSION",
"dea_schedule": null,
"strength_unit": "mg/g; mg/g; mg/g; mg/g",
"application_number": "M020",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about homosalate; octocrylene; avobenzone; octisalate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.